These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2135412)

  • 21. Microarray-based identification of human antibodies against Staphylococcus aureus antigens.
    Kloppot P; Selle M; Kohler C; Stentzel S; Fuchs S; Liebscher V; Müller E; Kale D; Ohlsen K; Bröker BM; Zipfel PF; Kahl BC; Ehricht R; Hecker M; Engelmann S
    Proteomics Clin Appl; 2015 Dec; 9(11-12):1003-11. PubMed ID: 25676254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus.
    Etz H; Minh DB; Henics T; Dryla A; Winkler B; Triska C; Boyd AP; Söllner J; Schmidt W; von Ahsen U; Buschle M; Gill SR; Kolonay J; Khalak H; Fraser CM; von Gabain A; Nagy E; Meinke A
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6573-8. PubMed ID: 11997460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitogenic activity of cytoplasmic membranes isolated from L-forms of Staphylococcus aureus.
    Takada H; Hirachi Y; Hashizume H; Kotani S
    Microbiol Immunol; 1980; 24(11):1079-90. PubMed ID: 7219205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of anti-Staphylococcus aureus-specific IgE in patients with atopic dermatitis.
    Yamada H; Yudate T; Orita T; Tezuka T
    J Clin Lab Immunol; 1996; 48(4):167-75. PubMed ID: 9819668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
    Gemmell CG
    Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Common antigens of stable group A streptococcal L forms and muscle fibers of human myocardium].
    Beletskaia LV; Vul'fovich IuV; Gnezditskaia EV; Goncharova SA; Ugriumova GA
    Biull Eksp Biol Med; 1978 Aug; 86(8):207-9. PubMed ID: 356911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].
    Takei S; Arora YK; Walker SM
    J Clin Invest; 1993 Feb; 91(2):602-7. PubMed ID: 8432865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera].
    Yoshida K; Ichiman Y; Ohshima Y; Hata H
    Kansenshogaku Zasshi; 1985 May; 59(5):433-8. PubMed ID: 3932531
    [No Abstract]   [Full Text] [Related]  

  • 29. Successive extraction of specific protective immunoglobulins from pooled human sera.
    Yoshida K; Ichiman Y
    J Clin Microbiol; 1984 Sep; 20(3):461-4. PubMed ID: 6386863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antigen localization in Streptococcus group A, L forms and revertant by an immunoferritin method].
    Churilova NS; Goncharova SA; Vul'fovich IuV; Konstantinova ND; Kats LN
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jun; (6):95-8. PubMed ID: 7051699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogenic effect of cytoplasmic membranes and a cytoplasmic fraction of Staphylococcus aureus L-forms on human peripheral blood lymphocytes.
    Takada H; Hirachi Y; Hashizume H; Kotani S
    Microbiol Immunol; 1981; 25(3):317-26. PubMed ID: 6973057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the h1 protein antigen from Staphylococcus aureus 17A.
    Kleppe G
    Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):279-83. PubMed ID: 6171993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid composition of autoplast and stable L-form from Staphylococcus aureus (author's transl)].
    Hayami M
    Nihon Saikingaku Zasshi; 1979 Jul; 34(4):685-92. PubMed ID: 537162
    [No Abstract]   [Full Text] [Related]  

  • 34. Extracellular membranous structures in a stable L-form of Staphylococcus aureus.
    Eda T; Kanda Y; Mori C; Kimura S
    J Gen Microbiol; 1977 Nov; 103(1):189-91. PubMed ID: 591922
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ultrastructure of L forms. Report 5. localization of dehydrogenase activity in L form cells].
    Kats LN; Konstantinova ND; Kharat'ian EF
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):67-9. PubMed ID: 817550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the binding of penicillin G to staphylococcal L-form and its parent strain membranes.
    Suginaka H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):544-5. PubMed ID: 1259410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of trypsin on the growth of Staphylococcus aureus and glycolytic effect of the yeast cell].
    ANGYAL J
    Kiserl Orvostud; 1954 Jan; 6(1):30-4. PubMed ID: 13164137
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effects of serum in long term cultivation of Staphylococcus aureus L-forms].
    Hibi E; Yoshizaki N; Takahashi M; Takei M
    Aichi Gakuin Daigaku Shigakkai Shi; 1975 Sep; 13(2):169-76. PubMed ID: 1070251
    [No Abstract]   [Full Text] [Related]  

  • 39. Supramolecular structure in the membrane of Staphylococcus aureus.
    García-Lara J; Weihs F; Ma X; Walker L; Chaudhuri RR; Kasturiarachchi J; Crossley H; Golestanian R; Foster SJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):15725-30. PubMed ID: 26644587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microtubular structures in a stable staphylococcal L-form.
    Eda T; Kanda Y; Mori C; Kimura S
    J Bacteriol; 1977 Dec; 132(3):1024-6. PubMed ID: 924970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.